tiprankstipranks
Trending News
More News >
Acurx Pharmaceuticals (ACXP)
NASDAQ:ACXP
US Market

Acurx Pharmaceuticals (ACXP) Income Statement

Compare
315 Followers

Acurx Pharmaceuticals Income Statement

Last quarter (Q3 2025), Acurx Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Acurx Pharmaceuticals's net income was $-1.99M. See Acurx Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 14.10M$ 14.58M$ 12.09M$ 12.81M$ 4.60M
Depreciation and Amortization
$ 14.10M$ 0.00$ 0.00$ 0.00$ 4.60M
EBITDA
$ 0.00$ -14.58M$ -12.09M$ -12.81M$ 0.00
Operating Income
$ -14.10M$ -14.58M$ -12.09M$ -12.81M$ -4.60M
Other Income/Expenses
-$ 0.00$ 0.00$ 66.50K-
Pretax Income
$ -14.10M$ -14.58M$ -12.09M$ -12.75M$ -4.60M
Net Income
$ -14.10M$ -14.58M$ -12.09M$ -12.75M$ -4.60M
Per Share Metrics
Basic EPS
$ -17.59$ -23.01$ -22.36$ -24.96$ -9.28
Diluted EPS
$ -17.59$ -23.01$ -22.36$ -24.96$ -9.28
Weighted Average Shares Outstanding
851.55K 633.60K 540.80K 510.80K 495.80K
Weighted Average Shares Outstanding (Diluted)
851.55K 633.60K 540.80K 510.80K 495.80K
Currency in USD

Acurx Pharmaceuticals Earnings and Revenue History